AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14670577 — intervention group
Group type: EXPERIMENTAL
Intervention: Right hemisphere (RH) patients
Number of subjects: 118
Study 14670577 — intervention group
Group type: EXPERIMENTAL
Intervention: Left hemisphere (LH) patients
Number of subjects: 118
Study 14670577 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 118
Study 10722036 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid (66 mg/kg per hour)
Number of subjects: 37
Study 10722036 — intervention group
Group type: COMPARATOR
Intervention: Control (no ascorbic acid)
Number of subjects: 37
Study 10722036 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid
Number of subjects: 37
Study 10722036 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 37
Study 8818095 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine containing adhesive tape (LT), applied 30 min before venipuncture
Number of subjects: 145
Study 8818095 — intervention group
Group type: COMPARATOR
Intervention: Control group (no LT)
Number of subjects: 145
Study 8818095 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine containing adhesive tape (LT)
Number of subjects: 145
Study 8818095 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert group (with LT)
Number of subjects: 145
Study 8818095 — intervention group
Group type: EXPERIMENTAL
Intervention: Novice group (with LT)
Number of subjects: 145
Study 1333105 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated (UF) heparin 5000 IU three times daily for 10 days
Number of subjects: 0
Study 1333105 — intervention group
Group type: COMPARATOR
Intervention: Low molecular weight (LMW) heparin (CY 216 D) 3100 IU once daily for 10 days
Number of subjects: 0
Study 6737408 — intervention group
Group type: EXPERIMENTAL
Intervention: Three interventions for mother and toddler problems
Number of subjects: 0
Study 6737408 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 31141834 — intervention group
Group type: EXPERIMENTAL
Intervention: Chicken meal
Number of subjects: 0
Study 31141834 — intervention group
Group type: EXPERIMENTAL
Intervention: Pork meal
Number of subjects: 0
Study 31141834 — intervention group
Group type: EXPERIMENTAL
Intervention: Beef meal
Number of subjects: 0
Study 31141834 — intervention group
Group type: COMPARATOR
Intervention: Control meal (egg white and pea)
Number of subjects: 0
Study 27687678 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/m2 cisplatin on 5 days every 4 weeks (group A)
Number of subjects: 170
Study 27687678 — intervention group
Group type: COMPARATOR
Intervention: 30-40 mg/m2 cisplatin weekly (group B)
Number of subjects: 170
Study 25912677 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness cognitive training group
Number of subjects: 45
Study 25912677 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness interoceptive training group
Number of subjects: 45
Study 25912677 — intervention group
Group type: COMPARATOR
Intervention: Non‐intervention control group
Number of subjects: 45
Study 23887901 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 12
Study 23887901 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study 21810108 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-help (GSH) intervention provided by primary care graduate mental health workers (PCGMHWs)
Number of subjects: 122
Study 21810108 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control (delayed treatment group)
Number of subjects: 122
Study 19627940 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-assisted gait training (RAGT)
Number of subjects: 67
Study 19627940 — intervention group
Group type: COMPARATOR
Intervention: Regular physiotherapy
Number of subjects: 67
Study 16704994 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft-tip catheter
Number of subjects: 540
Study 16704994 — intervention group
Group type: COMPARATOR
Intervention: Hard-tip catheter
Number of subjects: 540
Study 16248380 — intervention group
Group type: EXPERIMENTAL
Intervention: QGS (quantitative electrocardiography-gated myocardial perfusion single photon emission computed tomography)
Number of subjects: 46
Study 16248380 — intervention group
Group type: EXPERIMENTAL
Intervention: QGS
Number of subjects: 46
Study 16248380 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma BNP concentrations
Number of subjects: 46
Study 10912691 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical adrenaline application after myringotomy before tympanostomy tube placement
Number of subjects: 50
Study 10912691 — intervention group
Group type: COMPARATOR
Intervention: Saline application to contralateral ear after myringotomy
Number of subjects: 50
Study 9060957 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-examination instruction group (133375 women)
Number of subjects: 267040
Study 9060957 — intervention group
Group type: COMPARATOR
Intervention: Control group (133665 women)
Number of subjects: 267040
Study 9060957 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-examination instruction group
Number of subjects: 267040
Study 9060957 — intervention group
Group type: COMPARATOR
Intervention: Self-examination instruction group and Control group
Number of subjects: 267040
Study 8259772 — intervention group
Group type: EXPERIMENTAL
Intervention: Etidronate therapy (400 mg daily for 14 days, phosphate 1.0 g twice daily for 3 days, calcium 500 mg daily for the remainder of each 91-day cycle)
Number of subjects: 423
Study 8259772 — intervention group
Group type: EXPERIMENTAL
Intervention: Etidronate therapy
Number of subjects: 423
Study 8259772 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label intermittent cyclic etidronate therapy
Number of subjects: 423
Study 8259772 — intervention group
Group type: COMPARATOR
Intervention: Calcium supplementation
Number of subjects: 423
Study 3897204 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (55 mg/day)
Number of subjects: 44
Study 3897204 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (159 mg/day)
Number of subjects: 44
Study 2447297 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 0
Study 2447297 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 0
Study 2447297 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31818628 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban (10 mg once daily for 3 weeks)
Number of subjects: 646
Study 31818628 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for 3 weeks)
Number of subjects: 646
Study 31818628 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 646
Study 31818628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 646
Study 29885375 — intervention group
Group type: EXPERIMENTAL
Intervention: Age <65 years
Number of subjects: 6159
Study 29885375 — intervention group
Group type: EXPERIMENTAL
Intervention: Age 65-74 years
Number of subjects: 6159
Study 29885375 — intervention group
Group type: EXPERIMENTAL
Intervention: Age ≥75 years
Number of subjects: 6159
Study 28177189 — intervention group
Group type: EXPERIMENTAL
Intervention: High cortisol (c. 1400 nM) with high insulin
Number of subjects: 20
Study 28177189 — intervention group
Group type: EXPERIMENTAL
Intervention: High cortisol (c. 1400 nM) with low insulin
Number of subjects: 20
Study 28177189 — intervention group
Group type: EXPERIMENTAL
Intervention: High cortisol (c. 1400 nM) with adrenaline
Number of subjects: 20
Study 28177189 — intervention group
Group type: EXPERIMENTAL
Intervention: High cortisol (c. 1400 nM) in vitro with insulin
Number of subjects: 20
Study 28177189 — intervention group
Group type: EXPERIMENTAL
Intervention: High cortisol (c. 1400 nM) in vitro without insulin
Number of subjects: 20
Study 28177189 — intervention group
Group type: EXPERIMENTAL
Intervention: High cortisol (c. 1400 nM)
Number of subjects: 20
Study 26095467 — intervention group
Group type: COMPARATOR
Intervention: Limited screening (basic blood testing, chest radiography, and screening for breast, cervical, and prostate cancer)
Number of subjects: 854
Study 26095467 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited screening plus CT
Number of subjects: 854
Study 26095467 — intervention group
Group type: COMPARATOR
Intervention: Limited screening
Number of subjects: 854
Study 24124684 — intervention group
Group type: EXPERIMENTAL
Intervention: One-stop diagnosis and treatment group (CTU 3-D reconstruction, ultrasound and radiology guided puncture followed by PCNL)
Number of subjects: 210
Study 24124684 — intervention group
Group type: COMPARATOR
Intervention: Control group (PCNL without radiological guidance)
Number of subjects: 210
Study 21139017 — intervention group
Group type: EXPERIMENTAL
Intervention: Video calls
Number of subjects: 180
Study 21139017 — intervention group
Group type: COMPARATOR
Intervention: Ordinary mobile phone calls
Number of subjects: 180
Study 18679073 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Ecologic 641, containing four Lactobacillus and two Bifidobacillus strains)
Number of subjects: 14
Study 18679073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 16970649 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory stimulation with black pepper oil (BPO)
Number of subjects: 105
Study 14642409 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard methionine load
Number of subjects: 18
Study 14642409 — intervention group
Group type: COMPARATOR
Intervention: Control meal
Number of subjects: 18
Study 12212157 — intervention group
Group type: EXPERIMENTAL
Intervention: External irradiation and after-load intracavitary radiation in combination with traditional Chinese medicine (EIAIRC)
Number of subjects: 163
Study 12212157 — intervention group
Group type: EXPERIMENTAL
Intervention: External irradiation plus traditional Chinese medicine (EIC)
Number of subjects: 163
Study 12212157 — intervention group
Group type: COMPARATOR
Intervention: Standard radiotherapy (SRT)
Number of subjects: 163
Study 12212157 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM)
Number of subjects: 163
Study 8837569 — intervention group
Group type: COMPARATOR
Intervention: No medication (ischemia-none group)
Number of subjects: 131
Study 8837569 — intervention group
Group type: COMPARATOR
Intervention: Nitroglycerin (ischemia-NTG group)
Number of subjects: 131
Study 8837569 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (ischemia-nifedipine group)
Number of subjects: 131
Study 1450659 — intervention group
Group type: EXPERIMENTAL
Intervention: lodoxamide 0.1% ophthalmic solution
Number of subjects: 135
Study 1450659 — intervention group
Group type: COMPARATOR
Intervention: sodium cromoglycate 2% ophthalmic solution
Number of subjects: 135
Study 6375407 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg Doxycycline (DX)
Number of subjects: 44
Study 6375407 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 44
Study 6375407 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (DX)
Number of subjects: 44
Study 30891845 — intervention group
Group type: EXPERIMENTAL
Intervention: ATP provocation (A-P group)
Number of subjects: 107
Study 30891845 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacing (P-A group)
Number of subjects: 107
Study 30891845 — intervention group
Group type: COMPARATOR
Intervention: Combined approach (A-P and P-A groups)
Number of subjects: 107
Study 29568206 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-FODMAP rye bread
Number of subjects: 7
Study 29568206 — intervention group
Group type: COMPARATOR
Intervention: Regular rye bread
Number of subjects: 7
Study 27435790 — intervention group
Group type: EXPERIMENTAL
Intervention: Minilaparotomy cholecystectomy (MC)
Number of subjects: 106
Study 27435790 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 106
Study 27435790 — intervention group
Group type: EXPERIMENTAL
Intervention: Minilaparotomy cholecystectomy (MC) and Laparoscopic cholecystectomy (LC)
Number of subjects: 106
Study 23845740 — intervention group
Group type: COMPARATOR
Intervention: Metformin (1700 mg/die)
Number of subjects: 56
Study 23845740 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1700 mg/die) plus low-dose spironolactone (25 mg/die)
Number of subjects: 56
Study 22830441 — intervention group
Group type: EXPERIMENTAL
Intervention: DDD-70
Number of subjects: 1433
Study 22830441 — intervention group
Group type: EXPERIMENTAL
Intervention: DDDR-40
Number of subjects: 1433
Study 22830441 — intervention group
Group type: COMPARATOR
Intervention: DDD-40 (control arm)
Number of subjects: 1433
Study 20148739 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1500 mg)
Number of subjects: 30
Study 20148739 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle modification
Number of subjects: 30
Study 20148739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 20148739 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin + Lifestyle modification
Number of subjects: 30
Study 18506845 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine-scale curvature measurement in OA population
Number of subjects: 288
Study 18506845 — intervention group
Group type: EXPERIMENTAL
Intervention: Coarse-scale curvature measurement in OA population
Number of subjects: 288
Study 18506845 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine-scale curvature measurement in healthy and borderline OA populations (longitudinal study)
Number of subjects: 288
Study 18506845 — intervention group
Group type: EXPERIMENTAL
Intervention: Coarse-scale curvature measurement in severe OA populations (longitudinal study)
Number of subjects: 288
Study 18506845 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine-scale curvature prediction in healthy individuals at baseline
Number of subjects: 288
Study 15960556 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab plus methotrexate (MTX)
Number of subjects: 0
Study 15960556 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) alone
Number of subjects: 0
Study 11926427 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Kinesiology muscle test (verum)
Number of subjects: 7
Study 11926427 — intervention group
Group type: COMPARATOR
Intervention: Placebo (placebo bottles)
Number of subjects: 7
Study 9932655 — intervention group
Group type: EXPERIMENTAL
Intervention: 33 mmol/L bicarbonate solution
Number of subjects: 33
Study 9932655 — intervention group
Group type: COMPARATOR
Intervention: 40 mmol/L lactate solution
Number of subjects: 33
Study 7708260 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafiltration rate of 60 ml/min with dialysate calcium concentration of 1.63 mmol/l
Number of subjects: 0
Study 7708260 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafiltration rate of 100 ml/min with dialysate calcium concentration of 1.63 mmol/l
Number of subjects: 0
Study 7708260 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion rate of 2.5 l/h with dialysate calcium concentration of 1.63 mmol/l
Number of subjects: 0
Study 7708260 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion rate of 5 l/h with dialysate calcium concentration of 1.63 mmol/l
Number of subjects: 0
Study 7708260 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion rate of 2.5 l/h with dialysate calcium concentration of 1.5 mmol/l
Number of subjects: 0
Study 7708260 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion rate of 5 l/h with dialysate calcium concentration of 1.5 mmol/l
Number of subjects: 0
Study 7708260 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion rate of 2.5 l/h with dialysate calcium concentration of 1.25 mmol/l
Number of subjects: 0
Study 7708260 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion rate of 5 l/h with dialysate calcium concentration of 1.25 mmol/l
Number of subjects: 0
Study 2658462 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% sodium hyaluronate eye drops
Number of subjects: 20
Study 2658462 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% sodium hyaluronate eye drops
Number of subjects: 20
Study 2658462 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 2658462 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate treatment (both concentrations)
Number of subjects: 20
Study 30406819 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of amlodipine (10 mg/day) plus medium dose of ARB (high-AML)
Number of subjects: 67
Study 30406819 — intervention group
Group type: COMPARATOR
Intervention: Medium dose of amlodipine (5 mg/day) plus high dose of ARB (high-ARB)
Number of subjects: 67
Study 28375898 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity virtual reality arthroscopic simulator
Number of subjects: 40
Study 28375898 — intervention group
Group type: EXPERIMENTAL
Intervention: Bench-top arthroscopic setup
Number of subjects: 40
Study 28375898 — intervention group
Group type: COMPARATOR
Intervention: Untrained control group
Number of subjects: 40
Study 26073354 — intervention group
Group type: COMPARATOR
Intervention: Linagliptin 2.5 mg/metformin 850 mg
Number of subjects: 48
Study 26073354 — intervention group
Group type: COMPARATOR
Intervention: Linagliptin 2.5 mg/metformin 500 mg
Number of subjects: 48
Study 25610905 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobics exercise for 8 weeks
Number of subjects: 72
Study 25610905 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 72
Study 22927115 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 10
Study 19534294 — intervention group
Group type: EXPERIMENTAL
Intervention: NPH insulin (10U) injection into the carpal tunnel
Number of subjects: 50
Study 19534294 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 50
Study 17453298 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine (1000 mg/m²) every 7 days for 43 days
Number of subjects: 50
Study 17453298 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine (1000 mg/m²) and cisplatin (25 mg/m²)
Number of subjects: 50
Study 17453298 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 50
Study 14760320 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezafibrate (400 mg daily)
Number of subjects: 3122
Study 14760320 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3122
Study 11452568 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment twice weekly for 8 weeks
Number of subjects: 73
Study 11452568 — intervention group
Group type: COMPARATOR
Intervention: Crossover control group receiving acupuncture treatments twice weekly for 8 weeks
Number of subjects: 73
Study 9549270 — intervention group
Group type: EXPERIMENTAL
Intervention: Tape-recorded message from the attending surgeon
Number of subjects: 60
Study 8053360 — intervention group
Group type: EXPERIMENTAL
Intervention: Lights on
Number of subjects: 12
Study 8053360 — intervention group
Group type: COMPARATOR
Intervention: Lights off
Number of subjects: 12
Study 8053360 — intervention group
Group type: EXPERIMENTAL
Intervention: Participant sex
Number of subjects: 12
Study 8053360 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of target time
Number of subjects: 12
Study 8053360 — intervention group
Group type: COMPARATOR
Intervention: Lighting condition
Number of subjects: 12
Study 2656774 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (75 mg daily for 3 days)
Number of subjects: 8
Study 2656774 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (40 mg)
Number of subjects: 8
Study 2656774 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol with indomethacin
Number of subjects: 8
Study 2656774 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin pretreatment
Number of subjects: 8
Study 2656774 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 8
Study 31134333 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomisation (MR) analyses
Number of subjects: 0
Study 31134333 — intervention group
Group type: EXPERIMENTAL
Intervention: Tests for the null hypothesis of 'no causal effect'
Number of subjects: 0
Study 31134333 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear additive structural model
Number of subjects: 0
Study 31134333 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation of instruments
Number of subjects: 0
Study 29665733 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgical intervention (<24 hours post-injury)
Number of subjects: 86
Study 29665733 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone administration
Number of subjects: 86
Study 29665733 — intervention group
Group type: COMPARATOR
Intervention: AIS grade A patients
Number of subjects: 86
Study 29665733 — intervention group
Group type: COMPARATOR
Intervention: AIS grade B patients
Number of subjects: 86
Study 29665733 — intervention group
Group type: COMPARATOR
Intervention: AIS grade C patients
Number of subjects: 86
Study 29665733 — intervention group
Group type: COMPARATOR
Intervention: AIS grade D patients
Number of subjects: 86
Study 29665733 — intervention group
Group type: COMPARATOR
Intervention: Lower motor extremity score (LEMS) change for AIS A
Number of subjects: 86
Study 29665733 — intervention group
Group type: COMPARATOR
Intervention: Lower motor extremity score (LEMS) change for AIS B
Number of subjects: 86
Study 29665733 — intervention group
Group type: COMPARATOR
Intervention: Lower motor extremity score (LEMS) change for AIS C
Number of subjects: 86
Study 29665733 — intervention group
Group type: COMPARATOR
Intervention: Lower motor extremity score (LEMS) change for AIS D
Number of subjects: 86
Study 27681442 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanicemine 50 mg
Number of subjects: 302
Study 27681442 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanicemine 100 mg
Number of subjects: 302
Study 27681442 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 302
Study 25412724 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led HIV medication adherence intervention ('Ready')
Number of subjects: 20
Study 25412724 — intervention group
Group type: COMPARATOR
Intervention: Healthy eating control arm
Number of subjects: 20
Study 22749633 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy plans compliant with SIOPEN protocol guidelines
Number of subjects: 100
Study 22749633 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy plans with justifiable deviations
Number of subjects: 100